Concepedia

R. Foti

RF

Statistics

Publications

40

Citations

1.8K

H-Index

25

Active since

2002

Affiliations

Amgen (United States)(Current)

Pfizer (United States)

University of Washington

R. Foti is an author at Amgen (United States) specializing in medicine, biochemistry, and pharmacology.

ORCID

Top concepts

Publications per year

2002–2019

40

Publications

40

Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs

R. Foti, Michael B. Fisher · Forensic Science International · 2005 · 134 citations

, , +7

Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation

R. Foti, Dan A. Rock, Larry C. Wienkers et al. · Drug Metabolism and Disposition · 2010 · 129 citations

Cytochrome P450 and Non–Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics

R. Foti, Deepak Dalvie · Drug Metabolism and Disposition · 2016 · 110 citations

Fluoxetine- and Norfluoxetine-Mediated Complex Drug–Drug Interactions: In Vitro to In Vivo Correlation of Effects on CYP2D6, CYP2C19, and CYP3A4

Jennifer E. Sager, J. Lutz, R. Foti et al. · Clinical Pharmacology & Therapeutics · 2014 · 79 citations · Full text

, , +16

Prediction of CYP2D6 Drug Interactions from In Vitro Data: Evidence for Substrate-Dependent Inhibition

Brooke M. VandenBrink, R. Foti, Dan A. Rock et al. · Drug Metabolism and Disposition · 2011 · 77 citations

1–5 of 40